Enzalutamide: A Review in Castration-Resistant Prostate Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Link
http://link.springer.com/article/10.1007/s40265-018-1029-9/fulltext.html
Reference84 articles.
1. Attard G, Parker C, Eeles RA, et al. Prostate cancer. Lancet. 2016;387:70–82.
2. World Cancer Research Fund International. Prostate cancer statistics. 2018. https://www.wcrf.org/ . Accessed 8 Oct 2018.
3. Cornford P, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol. 2017;71(4):630–42.
4. NCCN. NCCN Clinical Practice Guidelines in Onoclogy: prostate cancer. 2017. https://www.nccn.org/ . Accessed 17 Nov 2018.
5. Schalken J, Fitzpatrick JM. Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer. BJU Int. 2016;117(2):215–25.
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer;Advanced Science;2023-11-10
2. Therapeutic Resistance Models and Treatment Sequencing in Advanced Prostate Cancer;Cancers;2023-11-03
3. The Complexity of Treatments and the Multidisciplinary Team—A Rare Case of Long-Term Progression—Free Survival in Prostate Cancer until Development of Liver and Brain Metastases;Journal of Clinical Medicine;2023-08-27
4. Is the Patient Actually Failing on Enzalutamide? A Case Report and Issues to Consider in Enzalutamide-Resistant Oligoprogressive Metastatic Castrate-Resistant Prostate Cancer;Reviews on Recent Clinical Trials;2023-05
5. Long noncoding RNA GHET1 promotes cell proliferation through oxidative stress in prostate cancer;Journal of Biochemical and Molecular Toxicology;2023-04-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3